The implementation time of insulin centralized collection and selection results shall be determined.
On January 6, the state organized the joint drug procurement office (hereinafter referred to as “joint procurement”) to issue the notice on publishing the first year agreed procurement volume of national centralized drug procurement (insulin special) through Shanghai Sunshine pharmaceutical procurement network. According to the notice, the results of this insulin special centralized purchase will be implemented in May 2022, and the specific implementation date shall be subject to the notice issued by all localities.
The notice mentioned that, according to the work arrangement, all pharmaceutical institutions have completed the confirmation of the agreed procurement volume of the selected products in the special insulin project, and the national first year agreed procurement volume and the first year agreed procurement volume of each region have been determined. Each insulin winning enterprise can log in to the “comprehensive service platform for centralized drug procurement organized by the state”, and click the “view agreed purchase quantity” menu in the “national procurement bidding management” on the left to view the agreed purchase quantity of the selected products of the enterprise.
The Sixth Batch of national drug centralized purchase is the special centralized purchase of insulin, which is also the first national drug centralized purchase of insulin. The quotation was opened in Shanghai on November 26. Finally, 11 enterprises participated in the bidding and all won the bid, including Novo Nordisk, Lilly, Sanofi, Gan & Lee Pharmaceuticals(603087) (603087), Tonghua Dongbao Pharmaceutical Co.Ltd(600867) (600867) and other Chinese and foreign enterprises.
In terms of decline, compared with the highest effective quotation of the insulin centralized purchase documents, the bid winning products have an average price reduction of 48%, with a maximum decline of more than 70%. According to the data previously released by the National Medical Insurance Bureau, according to the average price reduction, it is expected to save 9 billion yuan per year.
(surging News)
